Jianfeng Pharmaceutical Approved to Set up Provincial Research Institute

Release time:


A few days ago, the relevant departments of Zhejiang Province approved the establishment of the provincial research institute of the peak pharmaceutical company. This is another honor won by Jianfeng Pharmaceutical in the field of independent research and development and scientific and technological innovation after the national postdoctoral research workstation and Zhejiang academician expert workstation.

The provincial enterprise research institute is a high-level R & D institution led by the Provincial Department of Science and Technology, jointly recognized by the Provincial Economic and Information Commission and the Provincial Development and Reform Commission. As an important part of the national technological innovation system, the Enterprise Research Institute is the core force of the innovation-driven development of Jianfeng Pharmaceutical, which reflects the ability of Jianfeng Pharmaceutical to set up higher-level and higher-level R & D institutions on its own. the ability to gather and integrate innovation elements, organize scientific and technological innovation, support the sustainable development of enterprises, and lead the technological progress of the industry. As a pharmaceutical enterprise, scientific and technological innovation enterprise development eternal theme, and talent is the key to scientific and technological innovation. Over the years, Jianfeng Pharmaceutical has not only focused on cultivating its own scientific research talents, but also established close cooperative relations with well-known universities and scientific research institutions such as China Pharmaceutical University, Shenyang Pharmaceutical University, Sichuan Antibiotic Industry Research Institute, and also focused on introducing top think tanks. In 2011, Professor Liu Jiajian and his team from Sichuan Institute of Antibiotic Industry were introduced to focus on the technical research of key intermediates of methoxy cephalosporin. In 2013, Professor Shan Weiguang and his scientific research team from Zhejiang University of Technology were introduced to carry out research on preparation technology. In 2015, Professor Wang Guangji, academician of the Chinese Academy of Engineering, was hired as the chief scientist to organize the research on the anti-drug resistance mechanism of national first-drug drugs by using intracellular pharmacokinetics; in 2017, he discussed the cooperation of "internationalization of pharmaceutical preparations" project with Dr. Han Jun, chief scientist of Shanghai State Key Laboratory of antibody drugs and targeted therapy and "national thousand talents. Through the in-depth cooperation with the academician expert team, it provides intellectual support for enterprises, and lays a solid foundation for the independent innovation of Jianfeng pharmaceutical industry through the transformation of achievements and personnel training.

Huang Jinlong, deputy general manager of the group company and general manager of the pharmaceutical company, said that the establishment of the provincial research institute has built a better platform for the introduction of talents and technology. Jianfeng Pharmaceutical will further rely on scientific and technological innovation, steadily improve the ability of sustainable development, innovation leading ability and core competitiveness, and develop new technologies, new processes and new products with market prospects and competitiveness, so as to promote the sustained and steady development of enterprises.